Filter

Refine by collections

  • Paediatric Endocrinology (2)

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 2 of 2 items for :

  • "treatment initiation" x
  • Paediatric Endocrinology x
Clear All
Lukas Plachy Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic

Search for other papers by Lukas Plachy in
Google Scholar
PubMed Close
,
Lenka Petruzelkova Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic

Search for other papers by Lenka Petruzelkova in
Google Scholar
PubMed Close
,
Petra Dusatkova Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic

Search for other papers by Petra Dusatkova in
Google Scholar
PubMed Close
,
Klara Maratova Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic

Search for other papers by Klara Maratova in
Google Scholar
PubMed Close
,
Dana Zemkova Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic

Search for other papers by Dana Zemkova in
Google Scholar
PubMed Close
,
Lenka Elblova Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic

Search for other papers by Lenka Elblova in
Google Scholar
PubMed Close
,
Vit Neuman Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic

Search for other papers by Vit Neuman in
Google Scholar
PubMed Close
,
Stanislava Kolouskova Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic

Search for other papers by Stanislava Kolouskova in
Google Scholar
PubMed Close
,
Barbora Obermannova Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic

Search for other papers by Barbora Obermannova in
Google Scholar
PubMed Close
,
Marta Snajderova Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic

Search for other papers by Marta Snajderova in
Google Scholar
PubMed Close
,
Zdenek Sumnik Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic

Search for other papers by Zdenek Sumnik in
Google Scholar
PubMed Close
,
Jan Lebl Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic

Search for other papers by Jan Lebl in
Google Scholar
PubMed Close
, and
Stepanka Pruhova Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic

Search for other papers by Stepanka Pruhova in
Google Scholar
PubMed Close

) 5 (3–7) 5 (4–7) 0.85 Age at GH treatment initiation (years) 7 (5–9) 6 (5–9) 0.49 Average GH dose in the first year of treatment (ug/kg/day) 33 (32–36) 33 (31–35) 0.08 Average GH dose in the first year of treatment

Article Type:
Research Article
Collections:
Paediatric Endocrinology
DOI:
https://doi.org/10.1530/EC-23-0238
Volume/Issue:
Volume 12: Issue 10
Open access
Wolfgang Högler Department of Paediatrics and Adolescent Medicine, Johannes Kepler University Linz, Linz, Austria
Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK

Search for other papers by Wolfgang Högler in
Google Scholar
PubMed Close
,
Agnès Linglart AP-HP, Hôpital Bicêtre Paris Saclay, service d’endocrinologie et diabète de l’enfant, DMU 3 SEA, centre de référence des maladies rares du métabolisme du calcium et du phosphate, filière OSCAR; Université de Paris-Saclay INSERM U1185, Hôpital Bicêtre, Le Kremlin-Bicêtre, France

Search for other papers by Agnès Linglart in
Google Scholar
PubMed Close
,
Anna Petryk Alexion, AstraZeneca Rare Disease, Boston, Massachusetts, USA

Search for other papers by Anna Petryk in
Google Scholar
PubMed Close
,
Priya S Kishnani Duke University Medical Center, Durham, North Carolina, USA

Search for other papers by Priya S Kishnani in
Google Scholar
PubMed Close
,
Lothar Seefried University of Würzburg, Würzburg, Germany

Search for other papers by Lothar Seefried in
Google Scholar
PubMed Close
,
Shona Fang Alexion, AstraZeneca Rare Disease, Boston, Massachusetts, USA

Search for other papers by Shona Fang in
Google Scholar
PubMed Close
,
Cheryl Rockman-Greenberg University of Manitoba, Winnipeg, Manitoba, Canada

Search for other papers by Cheryl Rockman-Greenberg in
Google Scholar
PubMed Close
,
Keiichi Ozono Osaka University, Suita, Osaka, Japan

Search for other papers by Keiichi Ozono in
Google Scholar
PubMed Close
,
Kathryn Dahir Vanderbilt University Medical Center, Nashville, Tennessee, USA

Search for other papers by Kathryn Dahir in
Google Scholar
PubMed Close
, and
Gabriel Ángel Martos-Moreno Departments of Pediatrics and Pediatric Endocrinology Hospital Infantil Universitario Niño Jesús, IIS La Princesa, Universidad Autónoma de Madrid, CIBERobn, ISCIII, Madrid, Spain

Search for other papers by Gabriel Ángel Martos-Moreno in
Google Scholar
PubMed Close

(asfotase alfa). Eligible patients were required to have available data on registry enrollment date, date of birth or age at registry enrollment, sex, asfotase alfa treatment start date (if treated), and at least one height measurement before treatment

Article Type:
Research Article
Collections:
Paediatric Endocrinology
DOI:
https://doi.org/10.1530/EC-22-0240
Volume/Issue:
Volume 12: Issue 5
Open access